摘要
食管胃结合部腺癌(AEG)的发病率全世界呈逐年上升趋势,而外科治疗在AEG的综合治疗中仍占据最重要地位。由于AEG肿瘤部位和生物学行为的特殊性,腹部外科医师与胸外科医师在淋巴结清扫策略、手术切除范围和手术径路选择上尚未完全达成共识。微创技术的发展使腹腔镜联合胸腔镜治疗AEG成为可能。随着新辅助治疗地位的提升,未来AEG的诊断与治疗亦需通过多学科团队协作模式共同完成。笔者从腹部外科医师的视角,总结AEG诊断与治疗的现状和争议,审视其研究进展。
The incidence of adenocarcinoma of esopha⁃gogastric junction(AEG)is increasing worldwide annually.Surgical resection still plays the most important role in multi⁃modality therapy for AEG.However,due to the specialities of tumor location and biological features,general surgeons and thoracic surgeons do not reach an agreement on regional lymph⁃adenectomy,extents of resection,surgical approaches,etc.The development of minimally invasive surgery makes it possible to operate by laparoscopy and thoracoscopy.With the promotion of neoadjuvant therapy,a multidisciplinary team will be essential for optimal diagnosis and treatment in the near future.From the developmental perspective of a general surgeon,the authors summarize current status and controversies of the diagnosis and treatment of AEG,and inspect its research advances.
作者
赵恩昊
曹晖
Zhao Enhao;Cao Hui(Department of Gastrointestinal Surgery,Renji Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200127,China)
出处
《中华消化外科杂志》
CAS
CSCD
北大核心
2020年第6期598-603,共6页
Chinese Journal of Digestive Surgery
基金
国家自然科学基金面上项目(81802313)
上海交通大学医工交叉研究基金(YG2019QNB20)。
关键词
食管胃结合部肿瘤
腺癌
外科手术
淋巴结清扫
新辅助治疗
多学科团队
腹腔镜检查
Neoplasms of esophagogastric junction
adenocarcinoma
Surgical procedure
operative
Lymph node dissection
Neoadjuvant therapy
Multidiscipli⁃nary team
Laparoscopy
